Clicky

OraSure Technologies, Inc.(OSUR)

Description: OraSure Technologies, Inc. develops, manufactures, and markets oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies. Its diagnostic products include tests that are performed on a rapid basis at the point of care; and tests, which are processed in a laboratory. The principal products comprise OraQuick ADVANCE HIV-1/2, OraQuick In-Home HIV Test, OraQuick HCV, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene DISCOVER, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, Intercept, MICRO-PLATE DOA Assays, Homogeneous DOA Assays, and professional and over-the-counter Cryosurgical Systems. In addition, the company, through its subsidiary, DNA Genotek Inc., manufactures and sell kits used to collect, stabilize, and store samples of genetic material for molecular testing in the academic research, clinical genetic testing, pharmacogenomics, personalized medicine, and animal and livestock genetics markets. Its OraGene DNA sample collection kit provides an all-in-one system for the collection, stabilization, and transportation of DNA from human saliva. Further, the company offers medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Additionally, it sells certain immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and the FDA 510(k) cleared Q.E.D. rapid point-of-care saliva alcohol test. The company sells its products to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities in the United States and internationally. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.


Keywords: Medicine Clinic Public Health Alcohol Genomics Diagnostic Products HIV Medical Test Genetics FDA Immunoassay Toxicology HIV/Aids Genetic Testing Personalized Medicine Risk Assessment HCV Pharmacogenomics Surgical Systems Diagnosis Of Hiv/Aids

Home Page: www.orasure.com

OSUR Technical Analysis

220 East First Street
Bethlehem, PA 18015
United States
Phone: 610 882 1820


Officers

Name Title
Mr. Scott Gleason Sr. VP of Investor Relations & Corp. Communications
Ms. Kathleen Gallagher Weber Chief Product Officer
Ms. Carrie Eglinton Manner Pres, CEO & Director
Mr. Kenneth J. McGrath Chief Financial Officer
Ms. Michele Marie Miller Sr. VP, Chief Accounting Officer, Controller & Assistant Sec.
Mr. Stefano Taucer Gen. Counsel & Corp. Sec.
Mr. David A. Rappaport C.F.A., CFA Sr. VP Corp. Devel., Strategy & Integration
Amy Steigerwalt Sr. VP of HR
Mr. Zachary Wert Sr. VP of Global Operations
Ms. Trace Custer Sr. VP of Quality & Regulatory

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.1173
Price-to-Sales TTM: 1.1226
IPO Date: 1986-11-12
Fiscal Year End: December
Full Time Employees: 785
Back to stocks